158 related articles for article (PubMed ID: 36907571)
21. Outcome of inoperable hepatocellular carcinoma patients receiving transarterial chemoembolisation: a real-life retrospective analysis in a Hong Kong regional hospital.
Yip WM; Hung HG; Lok KH; Li KF; Li KK; Szeto ML
Hong Kong Med J; 2009 Oct; 15(5):339-45. PubMed ID: 19801690
[TBL] [Abstract][Full Text] [Related]
22. A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma.
Teng Y; Ding X; Li W; Sun W; Chen J
Technol Cancer Res Treat; 2022; 21():15330338221075174. PubMed ID: 35313780
[No Abstract] [Full Text] [Related]
23. New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.
Woo HY; Heo J
Clin Mol Hepatol; 2015 Jun; 21(2):115-21. PubMed ID: 26157747
[TBL] [Abstract][Full Text] [Related]
24. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization.
Padhani A
Radiology; 2009 Feb; 250(2):324-6. PubMed ID: 19188308
[No Abstract] [Full Text] [Related]
25. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
[TBL] [Abstract][Full Text] [Related]
26. Transarterial chemoembolization for hepatocellular carcinoma.
Lau WY; Yu SC; Lai EC; Leung TW
J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
[No Abstract] [Full Text] [Related]
27. Chemoembolization for small hepatocellular carcinoma.
Nakamura H; Oi H
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():144-7. PubMed ID: 9210897
[No Abstract] [Full Text] [Related]
28. Enhanced therapeutic efficacy of combined use of sorafenib and transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma.
Zhou L; Li J; Ai DL; Fu JL; Peng XM; Zhang LZ; Wang JY; Zhao Y; Yang B; Yu Q; Liu CZ; Wang HM
Jpn J Clin Oncol; 2014 Aug; 44(8):711-7. PubMed ID: 24855686
[TBL] [Abstract][Full Text] [Related]
29. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F
Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902
[No Abstract] [Full Text] [Related]
30. Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.
Luo J; Huang Z; Wang M; Li T; Huang J
BMC Gastroenterol; 2022 Mar; 22(1):108. PubMed ID: 35260095
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
Huang YH; Chen W; Li JP; Chen B; Yang JY
Chin Med J (Engl); 2013 Jan; 126(2):385-6. PubMed ID: 23324295
[No Abstract] [Full Text] [Related]
32. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
Qi X; Zhao Y; Li H; Guo X; Han G
Oncotarget; 2016 Jun; 7(23):34703-51. PubMed ID: 27167195
[TBL] [Abstract][Full Text] [Related]
33. Management of hepatocellular carcinoma: an update.
Bruix J; Sherman M;
Hepatology; 2011 Mar; 53(3):1020-2. PubMed ID: 21374666
[No Abstract] [Full Text] [Related]
34. Preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
Kobayashi T; Teruya M
Ann Surg; 2010 Feb; 251(2):386; author reply 386-7. PubMed ID: 20040849
[No Abstract] [Full Text] [Related]
35. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
Yau T; Tang VY; Yao TJ; Fan ST; Lo CM; Poon RT
Gastroenterology; 2014 Jun; 146(7):1691-700.e3. PubMed ID: 24583061
[TBL] [Abstract][Full Text] [Related]
36. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma.
Tsai WL; Liang PC; Chen CH
J Formos Med Assoc; 2012 Dec; 111(12):724-5. PubMed ID: 23265753
[No Abstract] [Full Text] [Related]
37. [Segmental simultaneous arterio-portal chemoembolization of hepatocellular carcinoma].
Oi H
Nihon Rinsho; 1991 Aug; 49(8):1910-5. PubMed ID: 1664898
[No Abstract] [Full Text] [Related]
38. Transcatheter arterial chemoembolization in hepatocellular carcinoma: technique, effects and present status.
Paul SB; Guglani B; Gulati MS; Batra Y; Mukhopadhyay S
Trop Gastroenterol; 2003; 24(4):176-84. PubMed ID: 15164527
[No Abstract] [Full Text] [Related]
39. Transarterial Chemoembolization in Combination with a Molecular Targeted Agent: Lessons Learned from Negative Trials (Post-TACE, BRISK-TA, SPACE, ORIENTAL, and TACE-2).
Kudo M; Arizumi T
Oncology; 2017; 93 Suppl 1():127-134. PubMed ID: 29258086
[TBL] [Abstract][Full Text] [Related]
40. Liver rupture after transcatheter arterial chemoembolization of a giant hepatocellular carcinoma.
Pijl ME; Pattynama PM; van Hoek B
J Vasc Interv Radiol; 1999; 10(7):895-7. PubMed ID: 10435707
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
